Home > Prevalence and impact of recreational drug use in patients with acute cardiovascular events.

Pezel, Théo and Dillinger, Jean-Guillaume and Trimaille, Antonin and Delmas, Clément and Piliero, Nicolas and Bouleti, Claire and Pommier, Thibaut and El Ouahidi, Amine and Andrieu, Stéphane and Lattuca, Benoit and Rossanaly Vasram, Reza and Fard, Damien and Noirclerc, Nathalie and Bonnet, Guillaume and Goralski, Marc and Elbaz, Meyer and Deney, Antoine and Schurtz, Guillaume and Docq, Clemence and Roubille, Francois and Fauvel, Charles and Bochaton, Thomas and Aboyans, Victor and Boccara, Franck and Puymirat, Etienne and Batisse, Anne and Steg, Gabriel and Vicaut, Eric and Henry, Patrick (2023) Prevalence and impact of recreational drug use in patients with acute cardiovascular events. Heart, doi: 10.1136/heartjnl-2023-322520.

External website: https://heart.bmj.com/content/early/2023/07/11/hea...


OBJECTIVE: While recreational drug use is a risk factor for cardiovascular events, its exact prevalence and prognostic impact in patients admitted for these events are not established. We aimed to assess the prevalence of recreational drug use and its association with in-hospital major adverse events (MAEs) in patients admitted to intensive cardiac care units (ICCU).

METHODS: In the Addiction in Intensive Cardiac Care Units (ADDICT-ICCU) study, systematic screening for recreational drugs was performed by prospective urinary testing all patients admitted to ICCU in 39 French centres from 7 to 22 April 2021. The primary outcome was prevalence of recreational drug detection. In-hospital MAEs were defined by death, resuscitated cardiac arrest, or haemodynamic shock.

RESULTS: Of 1499 consecutive patients (63±15 years, 70% male), 161 (11%) had a positive test for recreational drugs (cannabis 9.1%, opioids 2.1%, cocaine 1.7%, amphetamines 0.7%, 3,4-methylenedioxymethamphetamine (MDMA) 0.6%). Only 57% of these patients declared recreational drug use. Patients who used recreational drugs exhibited a higher MAE rate than others (13% vs 3%, respectively, p<0.001). Recreational drugs were associated with a higher rate of in-hospital MAEs after adjustment for comorbidities. After adjustment, cannabis, cocaine, and MDMA, assessed separately, were independently associated with in-hospital MAEs. Multiple drug detection was frequent (28% of positive patients) and associated with an even higher incidence of MAEs.

CONCLUSION: The prevalence of recreational drug use in patients hospitalised in ICCU was 11%. Recreational drug detection was independently associated with worse in-hospital outcomes.

[See also, editorial: Hospitalisation due to acute cardiovascular conditions: is screening for recreational drug use justified?]

Repository Staff Only: item control page